FDA Inspection 1150443 — Sovereign Pharmaceuticals, LLC

Sovereign Pharmaceuticals, LLC — FEI 3003229412

The FDA completed an inspection of Sovereign Pharmaceuticals, LLC on September 1, 2021 in Fort Worth, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 1, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fort Worth, TX (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
220521 CFR 211.186(b)(9)Manufacturing Instructions and Specifications
360321 CFR 211.160(b)Scientifically sound laboratory controls